Showing 161 - 180 results of 349 for search '"Institute of Medicine"', query time: 0.09s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169

    The Determinants of Adolescent Glycolipid Metabolism Disorder: A Cohort Study by Xiao-Hua Liang, Lun Xiao, Jing-Yu Chen, Ping Qu, Xian Tang, Yuwei Wang

    Published 2022-01-01
    “…Subjects with an urban residence, no pubertal development, dyslipidemia in 2014, higher family income, and higher parental education had significantly elevated fasting insulin (FI) or homeostasis model assessment of insulin resistance (HOMA-IR) levels; subjects with female sex, no pubertal development, dyslipidemia in 2014, obesity, gestational hypertension, maternal weight gain above Institute of Medicine guidelines, and single parents had increased triglyceride or triglyceride/high-density lipoprotein (HDL). …”
    Get full text
    Article
  10. 170
  11. 171
  12. 172
  13. 173
  14. 174

    Using a Two-Steps Clustering and PCA Analysis for Stratified Chronic Non-Cancer Pain Care: A Retrospective Cross-Sectional Study by Peiró AM, Barrachina J, Escorial M, Aguado I, Margarit C, Grimby-Ekman A

    Published 2025-02-01
    “…Ana M Peiró,1,2 Jordi Barrachina,1 Mónica Escorial,1 Isidro Aguado,1 César Margarit,1,3 Anna Grimby-Ekman4 1Neuropharmacology Applied to Pain (NED), Clinical Pharmacology Unit, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, 03010, Spain; 2Institute of Bioengineering, University Miguel Hernández, Elche, 03202, Spain; 3Pain Unit, Alicante Department of Health -General Hospital, Alicante, 03010, Spain; 4School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenCorrespondence: Ana M Peiró, Alicante Institute for Health and Biomedical Research (ISABIAL), Hospital General Universitario Doctor Balmis, c/Pintor Baeza, 12, Alicante, 03010, Spain, Email apeiro@umh.esPurpose: Given the number of people who suffer from chronic pain and the impact on healthcare resources, it is imperative that the people with pain receive an appropriate matched treatment due and stratified care. …”
    Get full text
    Article
  15. 175

    Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment by Ullah A, Khan M, Zhang Y, Shafiq M, Ullah M, Abbas A, Xianxiang X, Chen G, Diao Y

    Published 2025-01-01
    “…Aftab Ullah,1,* Marina Khan,2,* Yibang Zhang,3 Muhammad Shafiq,4 Mohsan Ullah,1 Azar Abbas,5 Xu Xianxiang,1 Gang Chen,6,7 Yong Diao1 1School of Medicine, Huaqiao University, Quanzhou, Fujian, People’s Republic of China; 2Department of Biotechnology and Genetic Engineering, Kohat University of Science and Technology, Kohat, Pakistan; 3School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China; 4Research Institute of Clinical Pharmacy, Department of Pharmacology, Shantou University Medical College, Shantou, Guangdong, People’s Republic of China; 5Institute of Medicine, Shenzhen Institute of Advanced Technology, Shenzhen, Guangdong, People’s Republic of China; 6School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao, Shandong, People’s Republic of China; 7Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao central Medical Group), Qingdao, Shandong, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yong Diao; Yibang Zhang, Email diaoyong@hqu.edu.cn; zhangyb@ujs.edu.cnAbstract: The effective clinical translation of messenger RNA (mRNA), small interfering RNA (siRNA), and microRNA (miRNA) for therapeutic purposes hinges on the development of efficient delivery systems. …”
    Get full text
    Article
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180